Position Statement on the Use of Benzodiazepine in Patients Receiving Buprenorphine Treatment, Christy Huff, M.D., A.J. Reid Finlayson, M.D.
What do hypnotics cost hospitals and healthcare?, Daniel Kripke, M.D.
Study examines factors that boost suicide risk for doctors, A.J. Reid Finlayson, M.D.
Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit, Daniel F. Kripke, M.D.
Social Networking and Benzodiazepine Withdrawal: The Reality of Dependence and Necessity of Support, Catherine Pittman, Ph.D.
Meta-analyses of hypnotics and infections: eszopiclone, ramelteon, zaleplon, and zolpidem, Daniel F. Kripke, M.D.
Medical and Consumer Outreach
Dependence Lunch and Learn
Board member Lisa von Braun, N.P. presenting to consumers and providers about benzodiazepine dangers and dependence at a lunch and learn 7/3/18, Laconia, New Hampshire.